Active Surveillance

Active Surveillance is a clinical management strategy for low- or favorable‑risk localized prostate cancer in which curative treatment is intentionally deferred while the disease is closely monitored through protocolized assessments (e.g., PSA testing, digital rectal examination, imaging, and repeat biopsy) so that intervention is initiated only upon evidence of progression or reclassification to higher risk.

1.1K

Publications

63K

Citations

5.4K

Authors

1.4K

Institutions

Publications per year

2017–2026

474

Authors

5.4K

  1. PR
    Peter R. Carroll

    University of California, San Francisco, United States

    78 publications · 7K citations

    43

    h-index

  2. MR
    Matthew R. Cooperberg

    University of California, San Francisco, United States

    51 publications · 5.5K citations

    34

    h-index

  3. MJ
    Monique J. Roobol

    Erasmus MC, Netherlands

    53 publications · 4.6K citations

    34

    h-index

  4. JI
    Jonathan I. Epstein

    Johns Hopkins University, United States

    43 publications · 3.9K citations

    31

    h-index

  5. LK
    Laurence Klotz

    Sunnybrook Health Science Centre, Canada

    56 publications · 5.4K citations

    30

    h-index

1–5 of 5.4K

Venues

  1. The Journal of Urology

    162 publications · 10.5K citations

    60

    h-index

  2. European Urology

    61 publications · 7K citations

    46

    h-index

  3. British Journal of Urology

    108 publications · 5.1K citations

    42

    h-index

  4. Urology

    57 publications · 2K citations

    28

    h-index

  5. Cancer

    27 publications · 2K citations

    21

    h-index

1–5